Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 26-May 2015. Module: Canada Health Infoway English module (core metadata concept)
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 138071000087111 | IXIARO 6 micrograms per 0.5 milliliter suspension for injection Intercell AG (real clinical drug) | en | Fully specified name | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| 96171000087112 | IXIARO 6 micrograms per 0.5 milliliter suspension for injection Intercell AG | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| 96181000087114 | JE IXIARO IAG | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| 97371000087112 | EJ IXIARO IAG | fr | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway French module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| IXIARO 6 micrograms per 0.5 milliliter suspension for injection Intercell AG (real clinical drug) | Plays role | Active immunity stimulant role (role) | true | Inferred relationship | Some | ||
| IXIARO 6 micrograms per 0.5 milliliter suspension for injection Intercell AG (real clinical drug) | a une forme pharmaceutique (attribut) | forme pharmaceutique pour usage parentéral (forme pharmaceutique) | true | Inferred relationship | Some | ||
| IXIARO 6 micrograms per 0.5 milliliter suspension for injection Intercell AG (real clinical drug) | Count of base of active ingredient | un | false | Inferred relationship | Some | ||
| IXIARO 6 micrograms per 0.5 milliliter suspension for injection Intercell AG (real clinical drug) | Has supplier | Intercell AG (supplier) | true | Inferred relationship | Some | ||
| IXIARO 6 micrograms per 0.5 milliliter suspension for injection Intercell AG (real clinical drug) | a pour principe actif (attribut) | Inactivated whole Japanese encephalitis virus SA14-14-2 strain antigen | true | Inferred relationship | Some | 1 | |
| IXIARO 6 micrograms per 0.5 milliliter suspension for injection Intercell AG (real clinical drug) | est un(e) (attribut) | Vaccine product containing only inactivated whole Japanese encephalitis virus antigen (medicinal product) | true | Inferred relationship | Some | ||
| IXIARO 6 micrograms per 0.5 milliliter suspension for injection Intercell AG (real clinical drug) | est un(e) (attribut) | Product manufactured as parenteral dose form (product) | true | Inferred relationship | Some | ||
| IXIARO 6 micrograms per 0.5 milliliter suspension for injection Intercell AG (real clinical drug) | est un(e) (attribut) | Japanese B encephalitis vaccine (product) | false | Inferred relationship | Some | ||
| IXIARO 6 micrograms per 0.5 milliliter suspension for injection Intercell AG (real clinical drug) | a pour principe actif (attribut) | Japanese encephalitis virus vaccine (substance) | false | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Administered tradename codes for vaccines reference set (foundation metadata concept)
FHIR